Diabetes drug tested to shrink prostate tumors before surgery
NCT ID NCT04887935
Summary
This is a small, early-stage study to see if a drug called dapagliflozin, normally used for diabetes, is safe and tolerable for men with aggressive prostate cancer before they have surgery to remove the prostate. Researchers want to see if taking the pill daily for four weeks before the operation can help shrink the tumor. The main goal is to check for side effects and see if most men can complete the treatment as planned.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.